Advancing drug-drug interactions research: integrating AI-powered prediction, vulnerable populations, and regulatory insights
Drug-drug interactions (DDIs) pose a significant and intricate challenge in clinical pharmacotherapy, especially among older adults who often have chronic conditions that necessitate multiple medications. These interactions can undermine the effectiveness of treatments or lead to adverse drug reacti...
Saved in:
| Main Authors: | Wenzhun Huang, Xiao Wang, Yunhao Chen, Changqing Yu, Shanwen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1618701/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapy
by: Alexander Pil Henriksen, et al.
Published: (2025-01-01) -
Exploring potential drug-drug interactions in discharge prescriptions: ChatGPT's effectiveness in assessing those interactions
by: Rahi Bikram Thapa, et al.
Published: (2025-03-01) -
Fine-Tuning BiomedBERT with LoRA and Pseudo-Labeling for Accurate Drug–Drug Interactions Classification
by: Ioan-Flaviu Gheorghita, et al.
Published: (2025-08-01) -
Comprehensive list of preventative migraine headache medications without significant drug–drug interactions
by: Jay Dave, et al.
Published: (2024-12-01) -
SCATrans: semantic cross-attention transformer for drug–drug interaction predication through multimodal biomedical data
by: Shanwen Zhang, et al.
Published: (2025-06-01)